Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 148

1.

[Clinical features of adult-onset chronic active Epstein-Barr virus infection].

Kawamoto K, Miyoshi H, Seto M, Kimura H, Ohshima K.

Rinsho Ketsueki. 2019;60(8):944-952. doi: 10.11406/rinketsu.60.944. Japanese.

PMID:
31484894
2.

[Heterogeneity of genomic alterations and clinical aspects in peripheral T-cell lymphoma: future perspectives].

Yoshida N, Seto M, Ohshima K.

Rinsho Ketsueki. 2019;60(4):271-280. doi: 10.11406/rinketsu.60.271. Japanese.

PMID:
31068555
3.

Genetic drivers of oncogenic pathways in molecular subgroups of peripheral T-cell lymphoma.

Heavican TB, Bouska A, Yu J, Lone W, Amador C, Gong Q, Zhang W, Li Y, Dave BJ, Nairismägi ML, Greiner TC, Vose J, Weisenburger DD, Lachel C, Wang C, Fu K, Stevens JM, Lim ST, Ong CK, Gascoyne RD, Missiaglia E, Lemonnier F, Haioun C, Hartmann S, Pedersen MB, Laginestra MA, Wilcox RA, Teh BT, Yoshida N, Ohshima K, Seto M, Rosenwald A, Ott G, Campo E, Rimsza LM, Jaffe ES, Braziel RM, d'Amore F, Inghirami G, Bertoni F, de Leval L, Gaulard P, Staudt LM, McKeithan TW, Pileri S, Chan WC, Iqbal J.

Blood. 2019 Apr 11;133(15):1664-1676. doi: 10.1182/blood-2018-09-872549. Epub 2019 Feb 19.

PMID:
30782609
4.

Publisher Correction: Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Mar;4(3):544. doi: 10.1038/s41564-019-0387-8.

PMID:
30705423
5.

Defective Epstein-Barr virus in chronic active infection and haematological malignancy.

Okuno Y, Murata T, Sato Y, Muramatsu H, Ito Y, Watanabe T, Okuno T, Murakami N, Yoshida K, Sawada A, Inoue M, Kawa K, Seto M, Ohshima K, Shiraishi Y, Chiba K, Tanaka H, Miyano S, Narita Y, Yoshida M, Goshima F, Kawada JI, Nishida T, Kiyoi H, Kato S, Nakamura S, Morishima S, Yoshikawa T, Fujiwara S, Shimizu N, Isobe Y, Noguchi M, Kikuta A, Iwatsuki K, Takahashi Y, Kojima S, Ogawa S, Kimura H.

Nat Microbiol. 2019 Mar;4(3):404-413. doi: 10.1038/s41564-018-0334-0. Epub 2019 Jan 21. Erratum in: Nat Microbiol. 2019 Jan 30;:.

PMID:
30664667
6.

Human leukocyte antigen class II expression is a good prognostic factor in adult T-cell leukemia/lymphoma.

Takeuchi M, Miyoshi H, Asano N, Yoshida N, Yamada K, Yanagida E, Moritsubo M, Nakata M, Umeno T, Suzuki T, Komaki S, Muta H, Furuta T, Seto M, Ohshima K.

Haematologica. 2019 Aug;104(8):1626-1632. doi: 10.3324/haematol.2018.205567. Epub 2019 Jan 10.

7.

Analysis of GNA13 Protein in Follicular Lymphoma and its Association With Poor Prognosis.

Shimono J, Miyoshi H, Yoshida N, Kato T, Sato K, Sugio T, Miyawaki K, Kurita D, Sasaki Y, Kawamoto K, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Am J Surg Pathol. 2018 Nov;42(11):1466-1471. doi: 10.1097/PAS.0000000000000969.

8.

Clinicopathological analysis of immunohistochemical expression of retinoic acid-related orphan receptor-γt in peripheral T-cell lymphoma, not otherwise specified.

Yanagida E, Miyoshi H, Kawamoto K, Nakashima K, Matsuda K, Yamada K, Muto R, Nagafuji K, Seto M, Ohshima K.

Hum Pathol. 2018 Sep;79:86-92. doi: 10.1016/j.humpath.2018.05.002. Epub 2018 Jun 22.

PMID:
29775622
9.

Clinicopathological analysis of polyploid diffuse large B-cell lymphoma.

Shimono J, Miyoshi H, Kiyasu J, Kamimura T, Eto T, Miyagishima T, Nagafuji K, Seto M, Teshima T, Ohshima K.

PLoS One. 2018 Apr 11;13(4):e0194525. doi: 10.1371/journal.pone.0194525. eCollection 2018.

10.

Expression of programmed death ligand 1 is associated with poor prognosis in myeloid sarcoma patients.

Kawamoto K, Miyoshi H, Suzuki T, Kiyasu J, Yokoyama S, Sasaki Y, Sone H, Seto M, Takizawa J, Ohshima K.

Hematol Oncol. 2018 Aug;36(3):591-599. doi: 10.1002/hon.2506. Epub 2018 Mar 30.

PMID:
29602174
11.

Hepatitis C virus infection is an independent prognostic factor in follicular lymphoma.

Shimono J, Miyoshi H, Kato T, Sugio T, Miyawaki K, Kamimura T, Miyagishima T, Eto T, Imaizumi Y, Kato K, Nagafuji K, Akashi K, Seto M, Teshima T, Ohshima K.

Oncotarget. 2017 Dec 11;9(2):1717-1725. doi: 10.18632/oncotarget.23138. eCollection 2018 Jan 5.

12.

Expression pattern of immunosurveillance-related antigen in adult T cell leukaemia/lymphoma.

Asano N, Miyoshi H, Kato T, Shimono J, Yoshida N, Kurita D, Sasaki Y, Kawamoto K, Ohshima K, Seto M.

Histopathology. 2018 May;72(6):945-954. doi: 10.1111/his.13461. Epub 2018 Feb 21.

PMID:
29297942
13.

A distinct subtype of Epstein-Barr virus-positive T/NK-cell lymphoproliferative disorder: adult patients with chronic active Epstein-Barr virus infection-like features.

Kawamoto K, Miyoshi H, Suzuki T, Kozai Y, Kato K, Miyahara M, Yujiri T, Choi I, Fujimaki K, Muta T, Kume M, Moriguchi S, Tamura S, Kato T, Tagawa H, Makiyama J, Kanisawa Y, Sasaki Y, Kurita D, Yamada K, Shimono J, Sone H, Takizawa J, Seto M, Kimura H, Ohshima K.

Haematologica. 2018 Jun;103(6):1018-1028. doi: 10.3324/haematol.2017.174177. Epub 2017 Dec 14.

14.

Frequent expression of CD30 in extranodal NK/T-cell lymphoma: Potential therapeutic target for anti-CD30 antibody-based therapy.

Kawamoto K, Miyoshi H, Suzuki T, Sasaki Y, Yamada K, Yanagida E, Muto R, Kiryu M, Sone H, Seto M, Ohshima K, Takizawa J.

Hematol Oncol. 2018 Feb;36(1):166-173. doi: 10.1002/hon.2482. Epub 2017 Oct 20.

PMID:
29052238
15.

Clinicopathological features of primary splenic follicular lymphoma.

Shimono J, Miyoshi H, Kamimura T, Eto T, Miyagishima T, Sasaki Y, Kurita D, Kawamoto K, Nagafuji K, Seto M, Teshima T, Ohshima K.

Ann Hematol. 2017 Dec;96(12):2063-2070. doi: 10.1007/s00277-017-3139-y. Epub 2017 Oct 3.

PMID:
28975390
16.

Clinicopathological analysis in PTCL-NOS with CADM1 expression.

Kato T, Miyoshi H, Kobayashi S, Yoshida N, Imaizumi Y, Seto M, Uchimaru K, Miyazaki Y, Ohshima K.

Virchows Arch. 2017 Nov;471(5):659-666. doi: 10.1007/s00428-017-2233-9. Epub 2017 Sep 22.

PMID:
28940014
17.

Papillary thyroid carcinoma expressing CD20.

Sasaki Y, Seto M, Miyoshi H, Okada S, Yokoyama S, Ohshima A, Ohshima K.

Pathol Int. 2017 Jul;67(7):350-354. doi: 10.1111/pin.12548. Epub 2017 Jun 15.

PMID:
28618063
18.

Clinicopathological features of cryptococcal lymphadenitis and a review of literature.

Kawamoto K, Miyoshi H, Suzuki T, Muto R, Yamada K, Yanagida E, Koshino M, Sasaki Y, Takizawa J, Sone H, Sugita Y, Seto M, Ohshima K.

J Clin Exp Hematop. 2017 Jul 5;57(1):26-30. doi: 10.3960/jslrt.17011. Epub 2017 Jun 8. Review.

19.

Establishment of cell lines from adult T-cell leukemia cells dependent on negatively charged polymers.

Kagami Y, Uchiyama S, Kato H, Okada Y, Seto M, Kinoshita T.

J Clin Exp Hematop. 2017 Jul 5;57(1):9-14. doi: 10.3960/jslrt.16021. Epub 2017 Apr 18.

20.

Comparison of clinicopathological characteristics between T-cell prolymphocytic leukemia and peripheral T-cell lymphoma, not otherwise specified.

Kawamoto K, Miyoshi H, Yanagida E, Yoshida N, Kiyasu J, Kozai Y, Morikita T, Kato T, Suzushima H, Tamura S, Muta T, Kato K, Eto T, Seki R, Nagafuji K, Sone H, Takizawa J, Seto M, Ohshima K.

Eur J Haematol. 2017 May;98(5):459-466. doi: 10.1111/ejh.12856. Epub 2017 Mar 3.

PMID:
28129454

Supplemental Content

Loading ...
Support Center